![Kirk Bertelsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kirk Bertelsen
Hoofd Techniek/Wetenschap/O&O bij
VIRIDIAN THERAPEUTICS, INC.
Profiel
Kirk Bertelsen currently works at Viridian Therapeutics, Inc., as Senior VP & Head-Research from 2024.
Dr. Bertelsen also formerly worked at Magenta Therapeutics, Inc., as Head-Clinical Pharmacology.
Dr. Bertelsen received his undergraduate degree from the University of Oregon and doctorate degree from Sackler School of Graduate Biomedical Sciences.
Actieve functies van Kirk Bertelsen
| Bedrijven | Functie | Begin |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2024 |
Eerdere bekende functies van Kirk Bertelsen
| Bedrijven | Functie | Einde |
|---|---|---|
| MAGENTA THERAPEUTICS | Corporate Officer/Principal | - |
Opleiding van Kirk Bertelsen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sackler School of Graduate Biomedical Sciences
 Sackler School of Graduate Biomedical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
